kabutan

WAKAMOTO PHARMACEUTICAL CO.,LTD.(4512) Summary

4512
TSE Standard
WAKAMOTO PHARMACEUTICAL CO.,LTD.
281
JPY
+1
(+0.36%)
Dec 5, 1:22 pm JST
1.81
USD
Dec 4, 11:22 pm EST
Result
PTS
outside of trading hours
281
Dec 5, 10:30 am JST
Summary Chart Historical News Financial Result
PER
48.7
PBR
0.84
Yield
1.07%
Margin Trading Ratio
98.31
Stock Price
Dec 5, 2025
Opening Dec 5, 9:00 am
280 JPY 1.80 USD
Previous Close Dec 4
280 JPY 1.80 USD
High Dec 5, 12:30 pm
283 JPY 1.82 USD
Low Dec 5, 9:00 am
280 JPY 1.80 USD
Volume
13,800
Trading Value
4.00M JPY 0.02M USD
VWAP
280.54 JPY 1.81 USD
Minimum Trading Value
28,100 JPY 181 USD
Market Cap
9.79B JPY 0.06B USD
Number of Trades
15
Liquidity & Number of Trades
As of Dec 5, 2025
Liquidity
Slightly High
1-Year Average
468
1-Year High Feb 7, 2025
12,753
Margin Trading
Date Short Interest Long Margin Positions Ratio
Nov 28, 2025 44,400 774,000 17.43
Nov 21, 2025 39,700 801,200 20.18
Nov 14, 2025 45,400 842,000 18.55
Nov 7, 2025 63,200 856,700 13.56
Oct 31, 2025 82,500 885,300 10.73
Company Profile
WAKAMOTO PHARMACEUTICAL CO.,LTD. is known for its flagship product, the digestive medicine "Kyouryoku Wakamoto". The company's revenue is primarily driven by its ophthalmology and eye drop products, with additional focus on dental clinic supplies.
Sector
Pharmaceuticals
WAKAMOTO PHARMACEUTICAL CO.,LTD. primarily operates in the pharmaceutical industry, while also engaging in healthcare, global business, and real estate leasing. In its pharmaceutical division, the company focuses on ophthalmology, offering both brand-name and generic drugs, as well as supplements. The healthcare division manufactures and sells the flagship product "Kyouryoku Wakamoto", along with the medicinal toothpaste "Avantbeads" series and feminine care products like "Femiflora". The global business division exports products such as "Wakamoto" and raw materials to Asia and Europe, while also pursuing new licensing opportunities. Domestically, the company is involved in contract manufacturing and the production and sale of diagnostic reagents and raw materials. The real estate leasing business primarily revolves around rentals related to COREDO Muromachi.